We investigate possible realizations of exotic SU(N ) symmetry-protected topological (SPT) phases with alkaline-earth cold fermionic atoms loaded into one-dimensional optical lattices. A thorough study of twoorbital generalizations of the standard SU(N ) Fermi-Hubbard model, directly relevant to recent experiments, is performed. Using state-of-the-art analytical and numerical techniques, we map out the zero-temperature phase diagrams at half-filling and identify several Mott-insulating phases. While some of them are rather conventional (nondegenerate, charge-density wave, or spin-Peierls-like), we also identify, for even N , two distinct types of SPT phases: an orbital Haldane phase, analogous to a spin-N/2 Haldane phase, and a topological SU(N ) phase, which we fully characterize by its entanglement properties. We also propose sets of nonlocal order parameters that characterize the SU(N ) topological phases found here.
We investigate the zero-temperature phase diagram of two-orbital SU(N ) fermionic models at incommensurate filling which are directly relevant to strontium and ytterbium ultracold atoms loading into a one-dimensional optical lattice. Using a low-energy approach that takes into account explicitly the SU(N ) symmetry, we find that a spectral gap for the nuclear-spin degrees of freedom is formed for generic interactions. Several phases with one or two gapless modes are then stabilized which describe the competition between different density instabilities. In stark contrast to the N = 2 case, no dominant pairing instabilities emerge and the leading superfluid one is rather formed from bound states of 2N fermions.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.